ACRS · Aclaris Therapeutics, Inc.

Summary

Aclaris Therapeutics, Inc. filed an 8-K on March 9, 2026, with Items listed as N/A. The filing includes an Item 7.01 disclosure, which shall not be deemed 'filed' for purposes of Section 18 of the Exchange Act or otherwise subject to liability thereunder.

Key takeaways

• Filing date: 2026-03-09
• Form type: 8-K
• Items: N/A
• Item 7.01 disclosure present
• Item 7.01 not deemed 'filed' under Section 18 of the Exchange Act